Immunohistochemical analysis showed that the ratio of Ki67-positive cells was markedly lower in tumors with ARV-825 treatment than that in the control group (Figures 8E, F), illustrating the tumor-inhibiting effect of ARV-825. The gene discussed is MKI67; the disease is neoplasm.